BOGOTÁ, Colombia, Oct. 19, 2021 (GLOBE NEWSWIRE) – Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of grade cannabinoids pharmaceutical company, announced the beginning of a commercial alliance with Pharmalab Phl Laboratorios SAS (“Pharmalab”), a Colombian company dedicated to the wholesale trade of medicinal, cosmetic and toilet pharmaceutical products.
By virtue of this alliance, Clever Leaves will supply Pharmalab with magisterial cannabis medications for distribution in Colombia, with the aim of treating pathologies related to pain and inflammation. The signing of Decree 811, by President Duque, made this alliance possible because the new Decree allows drug stores in Colombia to sell magisterial formulas based on medical cannabis. This is a great step towards meeting the unmet needs of Colombian patients.
Clever Leaves’ multiple certifications, including the European Union Good Manufacturing Practices (EU GMP) Certification, INVIMA’s Good Manufacturing Practices (GMP) Certification, and the Good Agricultural and Harvesting Practices Certification (GACP) ), position the company as a highly qualified supplier to supply magisterial drugs from pharmaceutical grade cannabis.
Andrés Fajardo President of Clever Leaves, assured that “We are very proud that, from our crops in Pesca-Boyacá, and our extraction plant and laboratory in Tocancipá, we are supplying medicinal cannabis products, products grown by Colombians and for Colombians, to doctors and patients in our country. ”He added that“ the shared passion for fostering a healthier community makes this alliance with Pharmalab a historic opportunity to supply high-quality products in Colombia. We see that Pharmalab is the perfect partner to meet the expectations of patients in the country. “
“Having already found success in the therapeutic areas of rheumatology and pain management, Pharmalab considers cannabinoid-based therapies to be an innovative and effective complement to its efforts to address the negative symptoms of numerous conditions. Our team is ready to go. commercial activities in the coming days, “said Pharmalab Manager Mauricio Sierra.
“Colombia has a robust regulatory framework that has allowed it, in the last five years, to grow, project and position itself as a pioneer country in the Latin American market, now opening the doors for patients to have safe access to cannabis-based medicines Clever Leaves, as a large-scale supplier, with the collaboration of Pharmalab, will contribute significantly to the commercialization of medicinal cannabis products within Colombia “, concludes Andrés Fajardo.
Acerca de Clever Leaves Holdings Inc.
Clever Leaves is a multinational cannabis company with an emphasis on large-scale organic farming and pharmaceutical grade processing as cornerstones of its global cannabis business. With operations and investments in the United States, Canada, Colombia, Germany and Portugal, Clever Leaves has built an effective distribution network and a global presence, with a foundation built on capital efficiency and rapid growth. Clever Leaves aims to be one of the leading cannabis companies in the world, recognized for its principles, people and performance, while fostering a healthier global community. Clever Leaves has received multiple international certifications that have allowed it to increase its export and sales capacity of its operations in Colombia, including the European Union Good Manufacturing Practices Certification (EU GMP), Good Manufacturing Practices Certification (GMP) of the National Institute of Food and Drug Surveillance of Colombia – INVIMA, and Certification of Good Agricultural and Collection Practices (GACP). Clever Leaves received a license in Portugal from Infarmed, the Portuguese health authority, which allows Clever Leaves to grow, import and export dried flowers for medicinal and research purposes. Additionally, the Portuguese operation also received certification in accordance with the GACP and the IMC-GAP. For more information visit https://cleverleaves.com/en/home/.
About Laboratorios Pharmalab PHL SAS
Laboratorios Pharmalab PHL SAS is a company with a long history, distinguished by its continuous commitment to being dynamic, transparent and ethical. With a focus on the healthy development and proper care of the human body. The organization has been dedicated to the commercialization of a range of products for human health: medicines, dietary supplements, diagnostic reagents, cosmetics and specialized foods. With an extensive network of expert suppliers and partners committed to excellence and perfection, its marketing of pharmaceutical grade products meets the needs of both individuals and institutions involved in the provision and dispensing of healthcare technologies. Funded entirely by Colombian capital, Pharmalab looks to the future, with a focus on the markets of Colombia, Mexico and Ecuador.
Press contact:
Diana Sigüenza
Strategic Communications Director
+57310-236-8830
Diana.siguenza@cleverleaves.com
Commercial contact:
Gustavo Escobar
Commercial Director Latin America
+57-300-324-5874
gustavo.escobar@cleverleaves.com
Investor inquiry:
Cody Battle
Gateway Investor Relations
+1949-574-3860
CLVR@gatewayir.com
Pharmalab Press Contact:
Juan Camilo Sierra
+57-300-777-1682
jsierra@pharmalabsa.com
